OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!

XClose

2005 Ann Schreiber Grant Recipient – Ritu Salani

Ritu Salani, M.D.
Johns Hopkins University
DNA Fragments Might be a Way to Screen for Ovarian Cancer

Project Summary

Ovarian cancer is a leading cause of cancer deaths among women. The lack of an effective screening tool for these patients continues to result in a high mortality from the disease. This project, “The Development of a Hypersensitive DNA Integrity Assay to Detect Ovarian Cancer,” is designed to develop and assess a new technology to detect ovarian cancer by evaluating the integrity of DNA in ascites and plasma. By analyzing the length of DNA fragments, it may be possible to distinguish patients with ovarian cancer from patients with benign disease, which may lead to a diagnostic blood test.